Tumor-infiltrating lymphocytes produced more IFN-gamma and MART-1 CD8+ T-cells, along with inducing a decrease in FoxP3+ T-cells, in the injected melanoma lesions post-injection when compared to the untreated melanoma control. Here, CD8A is linked to melanoma.